Mark T. Lupa

Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts.

TheraTogs, Inc. provides intervention medical devices and postural training services. It offers physical rehabilitation systems that are worn under the client’s clothing to address neuromotor, orthopedic, and postural conditions in children and adults. The company founded by Beverly Cusick and Lee Taylor in 1997 and is headquartered in Telluride, CO.

Nutrinsic Corp. develops and produces animal feed ingredients primarily for aquaculture industry that use renewable resources. The firm concentrates its efforts on manufacturing approaches that take a long-view perspective on sustainability. The company was founded by Seth S. Terry and Andrew J. Logan in 2001 and is headquartered in Glendale, CO.

Sinopsys Surgical, Inc. provides medical devices and instruments to evaluate potential new surgical procedures for the treatment of sinusitis. It offers instruments for surgical procedure for the lacrimal glands. The company was founded by Harry Ross in 2011 and is headquartered in Boulder, CO.

EndoShape, Inc. commercializes medical devices. Its products include Medusa multicoil, animation and instructions, and computerized tomography (CT) imaging. The company was founded by Harold Tyber, Jeffrey Cstleberry and Robin Shandas in 2006 and is headquartered in Idaho Springs, CO.

Mosaic Biosciences, Inc. provides commercial research and development services. It conducts research on synthetic materials that support native tissue regeneration. The firm's solutions are designed for application in wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers. The company was founded by Martin Stanton, Chris Bowman, Kristi S. Anseth and Peter Mariner in 2009 and is headquartered in Boulder, CO.

ViroCyt, Inc. develops life science instrumentation and assays products for the analysis of viruses and microorganisms. The company was founded in 2012 and is headquartered in Broomfield, CO.

VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO.

High Country Venture LLC (High Country Venture) is a Venture Capital firm founded in 2005. High Country Venture LLC is headquartered in Boulder.